BioThings Explorer: A platform for distributed knowledge integration across biomedical APIs
BioThings Explorer:跨生物医学 API 的分布式知识集成平台
基本信息
- 批准号:10705399
- 负责人:
- 金额:$ 106.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-24 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAutomationBypassClientCommunitiesDataDatabasesEcosystemFailureGatekeepingIndividualInfrastructureKnowledgeMethodsModelingOutputProviderPythonsRegistriesResourcesRunningScheduleSemanticsSortingSourceStructureSystemThinnessapplication programming interfacedata ingestiondata integrationdata resourceimprovedknowledge graphknowledge integrationnon-complianceweb app
项目摘要
This proposal describes the BioThings Explorer (BTE) platform as an Autonomous Relay
Agent (ARA). Most data integration efforts (including many being pursued within Translator) are
based on building centralized data resources. These efforts typically involve building resourcespecific
data ingestion parsers, the outputs of which are assembled into knowledge graphs and
loaded into a local database (with neo4j being a popular option within Translator).
The BTE platform takes a complementary approach to data integration, focusing on a
distributed network of knowledge providers connected by application programming interfaces
(APIs). A proof-of-concept implementation of BTE is now complete (with demos available in
[1,2]). This implementation has three components (Figure 1): a distributed knowledge graph
(distributed-KG) based on many individual web APIs "in the wild", a meta-knowledge graph
(meta-KG) that describes compatibility of inputs and outputs between each API, and a BTE
python client that automates the planning and execution of queries across the API network.
Relative to centralized solutions, this distributed model offers several advantages. First, the API
ecosystem is easily extensible by the community since there is no gatekeeper controlling
access to a centralized resource. The scope and output of the BTE system will continuously and
automatically improve as the community-maintained registry of API components continues to
grow. Second, the data retrieved are always up-to-date with the source and not dependent on
having a frequent synchronization schedule. Third, the distributed model is more scalable to
heavy usage since the BTE client is run on each user's own computing infrastructure, bypassing
any centralized component that could become a single point of failure.
BTE also distinguishes itself from other federated API solutions by using semantically-precise
annotations of APIs as they exist, rather than mandating any changes to the API itself. These
API annotations describe API inputs and outputs in enough detail to support initiating the API
call and interpreting the result. In contrast, other federated approaches (including some within
Translator) require APIs to conform to a common API structure. However, requirements like
these have historically been significant barriers to widespread adoption, and thin API "wrappers"
around non-compliant APIs introduce additional complexity and technical points of failure.
The strengths of the current BTE implementation are the ease of adding new resources and the
automation of the query planning and execution. The critical challenge that we address in this
proposal is developing new methods to rank and sort the query path results that are retrieved
from BTE queries.
该提案将BioThings Explorer (BTE)平台描述为自治中继
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW I SU其他文献
ANDREW I SU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW I SU', 18)}}的其他基金
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
使用知识图、保险索赔数据和基因表达互补性对阿尔茨海默病进行复合重新定位
- 批准号:
10338152 - 财政年份:2020
- 资助金额:
$ 106.27万 - 项目类别:
BioThings Explorer: A platform for distributed knowledge integration across biomedical APIs
BioThings Explorer:跨生物医学 API 的分布式知识集成平台
- 批准号:
10056577 - 财政年份:2020
- 资助金额:
$ 106.27万 - 项目类别:
BioThings Explorer: A platform for distributed knowledge integration across biomedical APIs
BioThings Explorer:跨生物医学 API 的分布式知识集成平台
- 批准号:
10333462 - 财政年份:2020
- 资助金额:
$ 106.27万 - 项目类别:
BioThings Explorer: A platform for distributed knowledge integration across biomedical APIs
BioThings Explorer:跨生物医学 API 的分布式知识集成平台
- 批准号:
10547977 - 财政年份:2020
- 资助金额:
$ 106.27万 - 项目类别:
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
使用知识图、保险索赔数据和基因表达互补性对阿尔茨海默病进行复合重新定位
- 批准号:
10554439 - 财政年份:2020
- 资助金额:
$ 106.27万 - 项目类别:
Consortium for Viral Systems Biology Data Management and Bioinformatics Core
病毒系统生物学数据管理和生物信息学核心联盟
- 批准号:
10310602 - 财政年份:2018
- 资助金额:
$ 106.27万 - 项目类别:
Consortium for Viral Systems Biology Data Management and Bioinformatics Core
病毒系统生物学数据管理和生物信息学核心联盟
- 批准号:
10248830 - 财政年份:2018
- 资助金额:
$ 106.27万 - 项目类别:
Consortium for Viral Systems Biology Data Management and Bioinformatics Core
病毒系统生物学数据管理和生物信息学核心联盟
- 批准号:
10374716 - 财政年份:2018
- 资助金额:
$ 106.27万 - 项目类别:
Consortium for Viral Systems Biology Data Management and Bioinformatics Core
病毒系统生物学数据管理和生物信息学核心联盟
- 批准号:
10579083 - 财政年份:2018
- 资助金额:
$ 106.27万 - 项目类别:
Gene Wiki: expanding the ecosystem of community-intelligence resources
Gene Wiki:扩大社区情报资源的生态系统
- 批准号:
8891444 - 财政年份:2010
- 资助金额:
$ 106.27万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 106.27万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 106.27万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 106.27万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 106.27万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 106.27万 - 项目类别:
Standard Grant